Complete Blood Work Guide for Testosterone Replacement Therapy (TRT): What to Test and When

Testosterone Replacement Therapy (TRT) can be a life-changing treatment for men suffering from symptomatic hypogonadism. However, it's not a "set it and forget it" solution. Regular and comprehensive blood work is crucial for optimizing treatment, ensuring safety, and preventing potential side effects. This guide outlines the essential blood tests for men on TRT, when to perform them, and what the results signify.

Why is Blood Work So Important for TRT?

Monitoring blood parameters allows your healthcare provider to:

• Confirm Diagnosis: Before starting TRT, blood work establishes a baseline and confirms the diagnosis of hypogonadism.
• Optimize Dosing: Adjusting testosterone dosage to achieve optimal therapeutic levels while minimizing side effects.
• Monitor Safety: Identifying and addressing potential adverse effects of TRT, such as erythrocytosis, liver strain, or prostate issues.
• Assess Overall Health: TRT can influence various physiological systems, and monitoring these helps maintain overall well-being.
• Personalize Treatment: Every individual responds differently to TRT. Blood work provides objective data for personalized care.

Initial Baseline Blood Work (Before Starting TRT)

Before initiating TRT, a comprehensive panel is essential to confirm hypogonadism, rule out secondary causes, and establish baseline health markers.

Key Baseline Tests:

1. Total Testosterone:

   • Purpose: The primary diagnostic test for hypogonadism. Measures the total amount of testosterone in the blood (bound and unbound).
   • Timing: Typically drawn in the morning (between 7-10 AM) when testosterone levels are highest. Two separate morning measurements are often recommended to confirm low levels.
   • Normal Range: Generally 300-1000 ng/dL, though optimal ranges can vary. Symptomatic men with levels below 300 ng/dL are typically candidates for TRT.
   • Citation: Bhasin, S., et al. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744.

2. Free Testosterone:

   • Purpose: Measures the biologically active form of testosterone, unbound to proteins. This is often a more accurate indicator of tissue-available testosterone, especially in men with altered SHBG levels.
   • Timing: Same as Total Testosterone.
   • Normal Range: Varies by lab, often 50-210 pg/mL.

3. Sex Hormone Binding Globulin (SHBG):

   • Purpose: A protein that binds to testosterone, making it unavailable for tissue action. High SHBG can lead to low free testosterone even with normal total testosterone. Low SHBG can lead to high free testosterone.
   • Timing: Same as Total Testosterone.
   • Normal Range: Varies, typically 10-50 nmol/L.
   • Clinical Relevance: Influences the interpretation of total and free testosterone levels.

4. Luteinizing Hormone (LH) & Follicle-Stimulating Hormone (FSH):

   • Purpose: Pituitary hormones that stimulate testosterone production in the testes. Used to differentiate between primary (testicular failure - high LH/FSH) and secondary (pituitary/hypothalamic dysfunction - low or normal LH/FSH) hypogonadism.
   • Timing: Same as Total Testosterone.
   • Normal Range: Varies by lab, typically 1.8-8.6 IU/L for LH and 1.5-12.4 IU/L for FSH.

5. Estradiol (E2) - Sensitive Assay:

   • Purpose: Measures estrogen levels. Testosterone aromatizes into estrogen. Elevated estrogen can lead to side effects like gynecomastia, water retention, and mood swings. A sensitive assay is crucial as standard assays may be inaccurate at male physiological levels.
   • Timing: Same as Total Testosterone.
   • Normal Range: Varies, often 10-40 pg/mL.
   • Citation: Rhoden, E. L., & Morgentaler, A. (2004). Risks of testosterone replacement therapy and recommendations for monitoring. The New England Journal of Medicine, 350(10), 1017-1027.

6. Prolactin:

   • Purpose: Elevated prolactin can suppress testosterone production and may indicate a pituitary adenoma.
   • Timing: Same as Total Testosterone.
   • Normal Range: Varies, typically <15 ng/mL.

7. Complete Blood Count (CBC):

   • Purpose: To assess overall blood health, particularly red blood cell count (hematocrit and hemoglobin). TRT can increase red blood cell production, leading to erythrocytosis, which can increase the risk of blood clots.
   • Timing: Any time.
   • Normal Range: Hematocrit 40-54%, Hemoglobin 13.5-17.5 g/dL.

8. Prostate-Specific Antigen (PSA):

   • Purpose: A marker for prostate health. TRT can potentially stimulate prostate growth, so a baseline is essential, especially in men over 40-50 or with a family history of prostate cancer.
   • Timing: Any time.
   • Normal Range: Generally <4.0 ng/mL, but age-specific ranges apply.
   • Citation: Morgentaler, A. (2006). Testosterone replacement therapy and prostate cancer. The Urologic Clinics of North America, 33(4), 533-543.

9. Lipid Panel:

   • Purpose: To assess cholesterol levels (HDL, LDL, Total Cholesterol, Triglycerides). TRT can sometimes affect lipid profiles, though the impact is variable.
   • Timing: Fasting for 9-12 hours.
   • Normal Range: Varies, consult lab reference ranges.

10. Liver Function Tests (LFTs):

    • Purpose: To assess liver health (ALT, AST, ALP, Bilirubin). Oral testosterone can be hepatotoxic; injectable or transdermal forms are generally safer for the liver.
    • Timing: Any time.
    • Normal Range: Varies, consult lab reference ranges.

Follow-Up Blood Work During TRT

Once TRT is initiated, regular monitoring is crucial. The frequency and specific tests depend on the route of administration, individual response, and clinical judgment.

First Follow-Up (6-8 Weeks After Starting TRT or Dose Change):

This initial follow-up is critical to assess the immediate response to TRT and make initial dose adjustments.

• Total Testosterone:

  • Purpose: To ensure therapeutic levels are reached.
  • Timing:
    • Injections (e.g., Testosterone Cypionate/Enanthate): Mid-cycle (e.g., 3-4 days after an injection if injecting twice weekly). This provides an "average" level. Some providers prefer trough levels (just before the next injection) to ensure levels don't drop too low.
    • Transdermal (Gels/Creams): 2-4 hours after application.
  • Target Range: Generally 500-1000 ng/dL, with a focus on symptom resolution.

• Free Testosterone:

  • Purpose: To ensure adequate biologically active testosterone.
  • Timing: Same as Total Testosterone.

• Estradiol (E2) - Sensitive Assay:

  • Purpose: To monitor for elevated estrogen, which can lead to side effects.
  • Timing: Same as Total Testosterone.
  • Target Range: Often 20-30 pg/mL, but clinical symptoms are paramount.

• Complete Blood Count (CBC) - Specifically Hematocrit:

  • Purpose: To check for erythrocytosis.
  • Timing: Any time.
  • Action: If hematocrit >52%, consider dose reduction, increased hydration, or therapeutic phlebotomy.
  • Citation: Marks, L. S., et al. (2006). The effect of testosterone replacement on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism, 91(7), 2626-2633.

Ongoing Follow-Up (Every 3-6 Months for the First Year, then Annually):

Once stable, the frequency can be reduced, but annual checks are crucial.

• Total Testosterone:

  • Purpose: To ensure stable therapeutic levels.
  • Timing: As per initial follow-up, depending on administration route.

• Free Testosterone:

  • Purpose: To ensure stable biologically active testosterone.